LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Clinical trials for LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to stop deadly head & neck cancer from coming back
Disease control Not yet recruitingThis study compares two different drugs given after initial cancer treatment to prevent the cancer from returning in patients with advanced nasopharyngeal carcinoma (a type of head and neck cancer). About 218 patients who have completed their main cancer treatment will receive ei…
Matched conditions: LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated Apr 04, 2026 00:50 UTC
-
New Two-Drug attack on advanced throat cancer begins testing
Disease control Not yet recruitingThis study is testing whether adding two immunotherapy drugs (pembrolizumab and MRG-003) before and after standard chemoradiation can better control advanced nasopharyngeal cancer. It will involve about 35 adults with a specific type of this cancer linked to the Epstein-Barr viru…
Matched conditions: LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC